About Passage Bio (PASG)
Passage Bio Inc is a preclinical stage genetic medicines company. The Company is focused on developing transformative therapies for rare, monogenic central nervous system (CNS). The Company is developing a portfolio of six life transforming AAV-deliv... Read more
- USD1.15
- USD1.19
- USD1.12
- USD1.79
- -17.90%
- --
- 172.40k
- 71M
- 0.58
- 11.70%
Stock News
1 hour ago
Forget SoundHound AI: 3 Tech Stocks to Buy Instead
Yahoo
2 hours ago
This Is Hands Down My Pick for the Best "Magnificent Seven" Stock Right Now. (Hint: It's Not Nvidia.)
Yahoo
2 hours ago
Swipe Right on Safety: New Study from Norton Finds 64% of Online Daters are Interested in Using AI as a Dating Coach
Yahoo
3 hours ago
JD Sports Fashion Buys Hibbett, Valuing It at $1.1 Bln, in Push Into U.S. Market
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
